APOTHEEK PROXIPHAR
The computed 12-month bankruptcy probability of APOTHEEK PROXIPHAR is 0.6% (low). The 2024 annual accounts show equity of €243k and a net result of €66k. Equity is growing by ~13.5% per year across the filed fiscal years. Its solvency ranks better than 79% of 1230 sector peers (fiscal year 2024). The company has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €243k |
| Net result | €66k |
| Staff (FTE) | 0.8 |
| Better than sector | 79% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 52.9% | 20.3% | |
| Net result | €66k | €25k | |
| Equity | €243k | €142k | |
| Gross operating margin | €167k | €215k | |
| Staff costs | €60k | €160k |
Show 12 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €105k |
| Net profit | €66k |
| Cash flow | €74k |
| Staff costs | €60k |
| Income taxes | €26k |
| Dividends | €22k |
| Total assets | €460k |
| Equity | €243k |
| Debt | €217k |
| of which ≤ 1y | €194k |
| of which > 1y | €20k |
| Working capital | €122k |
| Employees (FTE) | 0.8 |
| 2024 | |
|---|---|
| Current ratio | 1.63 |
| Quick ratio | 1.14 |
| Working capital ratio | 26.4% |
| Solvency | 52.9% |
| Debt / equity | 0.89 |
| Long-term debt ratio | 0.08 |
| Interest coverage | 20.83 |
| Gross margin | - |
| Net margin | - |
| ROA | 14.4% |
| ROE | 27.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €460k |
| Fixed assets | 21/28 | €144k |
| Tangible fixed assets | 22/27 | €144k |
| Current assets | 29/58 | €316k |
| Stocks & contracts in progress | 3 | €94k |
| Amounts receivable within one year | 40/41 | €92k |
| Cash & bank | 54/58 | €120k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €460k |
| Equity | 10/15 | €243k |
| Contributions / capital | 10/11 | €21k |
| Reserves | 13 | €222k |
| Accumulated profits (losses) | 14 | €0 |
| Amounts payable | 17/49 | €217k |
| Amounts payable after one year | 17 | €20k |
| Amounts payable within one year | 42/48 | €194k |
| Trade debts payable within one year | 44 | €128k |
| Income statement | ||
| Gross operating margin | 9900 | €167k |
| Operating result | 9901 | €97k |
| Financial income | 75 | €15 |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €92k |
| Income taxes | 67/77 | €26k |
| Net result for the period | 9904 | €66k |
| Result to be appropriated | 9905 | €66k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 23-03-1999 |
| Status | Active |
| Postal code | 9040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44432C0962/00L003 | Flanders | 408 m² | 1 · 208 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
16-01-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Jeroen Parmentier",
"firm_city": null,
"firm_name": "NOTAS, geassocieerde notarissen",
"office_city": "Gent",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-16",
"filing_date": "2024-01-12",
"act_kind_objet": "DIVERSEN, WIJZIGING RECHTSVORM, STATUTEN (VERTALING,"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-07",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0465.693.931",
"name": "APOTHEEK PROXIPHAR",
"role": "other",
"address": "Doornakkerstraat 42 9040 Gent",
"is_foreign": false,
"legal_form": "BV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "COMPAD MANAGEMENT",
"role": "other",
"address": "Lijsterbesdreef 17 9040 Gent",
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0663.735.168",
"name": "Taccess",
"role": "other",
"address": "Maaltebruggestraat 169 9000 Gent",
"is_foreign": false,
"legal_form": "BV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"39 \u00A71"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0465.693.931",
"name_full": "APOTHEEK PROXIPHAR",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jeroen Parmentier",
"org_rep_person_name": null
},
"summary_narrative": "De algemene vergadering van APOTHEEK PROXIPHAR heeft besloten de statuten aan te passen aan de bepalingen van het Wetboek van vennootschappen en verenigingen, waarbij de rechtsvorm BV behouden blijft. Er zijn diverse wijzigingen aangebracht, waaronder de toevoeging van de mogelijkheid tot winstuitkering door het bestuursorgaan, het ontslag en herbenoemen van de bestuurder van COMPAD MANAGEMENT, en de aanname van volledig nieuwe statuten. De zetel is gevestigd in het Vlaams Gewest.",
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"de geco\u00F6rdineerde tekst van de statuten",
"op elektronische wijze de geco\u00F6rdineerde statuten neergelegd overeenkomstig artikel 2:7 WVV in het openbaar raadpleegbaar elektronisch databanksysteem"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}| Legal nameNL | APOTHEEK PROXIPHAR |